News | February 28, 2026
Eli Lilly and Incyte score key win for teens with severe alopecia areata in Europe
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
AA, a chronic immune disease, can cause extensive and unpredictable hair loss
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
This approval builds on the recent transformation RYBREVANT FASPRO brought to lung cancer care
Leading the showcase is FCT iStream, Fujifilm’s latest CT scanner built on a “Less is More” design philosophy
Nucala is the first and only monthly biologic in the EU evaluated in a wide COPD population with an eosinophilic phenotype
The Union Budget 2026–27 accords strong priority to the upgradation and expansion of healthcare infrastructure and medical education
The guidelines also support reusing tenofovir and abacavir in later regimens for improved outcomes, cost savings, and programmatic efficiency
This is the first controlled pharmacologic study to demonstrate that treatment of obesity improved PsA disease measures
Mepolizumab is the first and only monthly biologic in China tested for COPD patients with blood eosinophil counts (BEC) as low as 150 cells/µL
Subscribe To Our Newsletter & Stay Updated
